Walter Callen

USPTO Granted Patents = 29 (Patent Applications = 5)

CIPO Patents = 7 (Patent Applications = 2)

EPO Patents = 13 (Patent Applications = 17)

Average Co-Inventor Count = 4.7

ph-index = 8

Forward Citations = 222(Granted Patents)

Company Filing History:

Syngenta Participations Ag

Bp Corporation North America Inc.

patents

where one patent can have more than one assignee

Years Active: 1999-2018

Loading Chart...

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10066222 - Amylases, nucleic acids encoding them and method of producing an oil (2018-09-04),

2. 10047350 - Enzymes having alpha amylase activity and methods of making and using them (2018-08-14),

3. 9765319 - Xylanases, nucleic acids encoding them and methods for making and using them (2017-09-19),

4. 9701950 - Amylases, nucleic acids encoding them and methods for making and using them (2017-07-11),

5. 9422536 - Glucanases, nucleic acids encoding them and methods for making and using them (2016-08-23),

6. 9062295 - Recombinant polypeptides (2015-06-23),

7. 8728769 - Xylanases, nucleic acids encoding them and methods for making and using them (2014-05-20),

8. 8338131 - Amylases and methods for use in starch processing (2012-12-25),

9. 8334118 - Enzymes having alpha amylase activity and methods of making and using them (2012-12-18),

10. 8222035 - Amylases, nucleic acids encoding them and methods for making and using them (2012-07-17),

11. 8148126 - Polymerase (2012-04-03),

12. 7960148 - Glucanases, nucleic acids encoding them and methods for making and using them (2011-06-14),

13. 7816108 - Methods for using polypeptides having amylase activity and nucleic acids encoding them (2010-10-19),

14. 7785855 - Nucleic acids encoding polypeptides having amylase activity and methods of making and using them (2010-08-31),

15. 7781201 - Polypeptides having amylase activity and methods of making and using them (2010-08-24),

Title: Innovations in Enzyme Technology: The Work of Walter Callen

Introduction

Walter Callen, based in San Diego, California, is a prominent inventor with an impressive portfolio of 29 patents. His innovative work primarily focuses on enzyme technology, particularly amylases, which are crucial in various biochemical processes.

Latest Patents

Among his latest patents are groundbreaking inventions related to amylases and nucleic acids encoding them. One notable patent directs focus to polypeptides with amylase activity, detailing methods for producing these polypeptides and how they can be applied in catalyzing the hydrolysis of starch into sugars. Additionally, he has developed alpha amylases that demonstrate increased activity and stability across various pH levels and temperatures. Furthermore, his work includes the design of new alpha amylases and their usage, showcasing his expertise in enhancing enzyme efficacy.

Career Highlights

Walter has made significant contributions during his time at various renowned companies. He has been associated with Verenium Corporation and Syngenta Participations AG, where he has further advanced his research in enzyme technology. His contributions have earned him recognition in the field of biotechnology.

Collaborations

Throughout his career, Walter has worked alongside esteemed colleagues, including Eric J. Mathur and Toby Howard Richardson. These collaborations have played a vital role in fostering innovation and pushing the boundaries of enzyme research.

Conclusion

Walter Callen's innovative spirit and dedication to developing advanced enzyme technologies have made him a key player in the biotechnology industry. His extensive patent portfolio reflects his commitment to scientific excellence and has paved the way for future advancements in enzyme applications. His work continues to inspire and influence research in this vital area of science.

This text is generated by artificial intelligence and may not be accurate.